Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000459333 | SCV000546161 | pathogenic | Jeune thoracic dystrophy | 2023-11-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg3536*) in the DYNC2H1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). This variant is present in population databases (rs562139820, gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with asphyxiating thoracic dystrophy (PMID: 23339108). ClinVar contains an entry for this variant (Variation ID: 407155). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001291287 | SCV005680473 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Dan Cohn Lab, |
RCV001291287 | SCV000612003 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291287 | SCV001479737 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | no assertion criteria provided | research |